The FDA-approved smoking cessation pill, varenicline, is showing remarkable promise in combating nicotine addiction, particularly among teens and young adults.A recent clinical trial conducted by researchers at Mass General Brigham revealed that adolescents using varenicline were more than three times as successful in quitting vaping compared to those given a placebo.